Recombinant multi-species RNF149 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF149 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent protein catabolic process. Predicted to act upstream of or within cellular response to xenobiotic stimulus; negative regulation of MAPK cascade; and regulation of protein stability. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: RNF149,E3 ubiquitin-protein ligase RNF149,DNA polymerase-transactivated protein 2, RING finger protein 149, RING-type E3 ubiquitin transferase RNF149,DNAPTP2

Target products collectionGo to RNF149 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1512-Ab-1/ GM-Tg-hg-IP1512-Ab-2 Human RNF149 protein Human
GM-Tg-rg-IP1512-Ab-1/ GM-Tg-rg-IP1512-Ab-2 Rat RNF149 protein Rat
GM-Tg-mg-IP1512-Ab-1/ GM-Tg-mg-IP1512-Ab-2 Mouse RNF149 protein Mouse
GM-Tg-cynog-IP1512-Ab-1/ GM-Tg-cynog-IP1512-Ab-2 Cynomolgus/Rhesus macaque RNF149 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1512-Ab-1/ GM-Tg-felg-IP1512-Ab-2 Feline RNF149 protein Feline
GM-Tg-cang-IP1512-Ab-1/ GM-Tg-cang-IP1512-Ab-2 Canine RNF149 protein Canine
GM-Tg-bovg-IP1512-Ab-1/ GM-Tg-bovg-IP1512-Ab-2 Bovine RNF149 protein Bovine
GM-Tg-equg-IP1512-Ab-1/ GM-Tg-equg-IP1512-Ab-2 Equine RNF149 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1512-Ab-1/ GM-Tg-hg-IP1512-Ab-2; GM-Tg-rg-IP1512-Ab-1/ GM-Tg-rg-IP1512-Ab-2;
GM-Tg-mg-IP1512-Ab-1/ GM-Tg-mg-IP1512-Ab-2; GM-Tg-cynog-IP1512-Ab-1/ GM-Tg-cynog-IP1512-Ab-2;
GM-Tg-felg-IP1512-Ab-1/ GM-Tg-felg-IP1512-Ab-2; GM-Tg-cang-IP1512-Ab-1/ GM-Tg-cang-IP1512-Ab-2;
GM-Tg-bovg-IP1512-Ab-1/ GM-Tg-bovg-IP1512-Ab-2; GM-Tg-equg-IP1512-Ab-1/ GM-Tg-equg-IP1512-Ab-2
Products Name RNF149 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF149
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF149 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.